Items Tagged ‘epidermal growth factor receptor’

July 17th, 2017

Personalized Precision Medicine Treatment of Colon Cancer: What Every Patient Should Know

By

The purpose of precision cancer medicine is not to categorize or classify cancers solely by site of origin, but to define the genomic alterations in the cancer’s DNA that are driving that specific cancer.  Precision cancer medicine utilizes molecular diagnostic testing, including DNA sequencing, to identify cancer-driving abnormalities in a cancer’s genome. Once a genetic abnormality […]

View full entry

Tags: Biomarkers, BRAF, Carcinoembryonic Antigen, CEA, cetuximab, Colon Cancer, colorectal cancer, EGFR, epidermal growth factor receptor, Genetic Mutations, kras, Microsatellite Instability High


December 19th, 2016

Tagrisso®: New Standard of Care for Certain Lung Cancer

By

Treatment with the targeted agent Tagrisso (osimertinib) significantly delayed cancer progression, and resulted in fewer side effects, than standard chemotherapy for patients with advanced non-small cell lung cancer (NSCLC) whose cancer had progressed following prior therapy with an epidermal growth factor receptor (EGFR) inhibitor. Lung cancer remains the leading cause of cancer-related deaths in the […]

View full entry

Tags: EGFR, epidermal growth factor receptor, General Lung Cancer, Lung Cancer, Lung Cancer - Non-Small Cell, News, nsclc, osimertinib, Stages IIIB-IV Lung Cancer - Non-Small Cell, T790 mutation, tagrisso